0001209191-19-058693.txt : 20191203
0001209191-19-058693.hdr.sgml : 20191203
20191203161655
ACCESSION NUMBER: 0001209191-19-058693
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191129
FILED AS OF DATE: 20191203
DATE AS OF CHANGE: 20191203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richardson Joshua
CENTRAL INDEX KEY: 0001793762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 191265986
MAIL ADDRESS:
STREET 1: C/O LONGITUDE CAPITAL
STREET 2: 2740 SAND HILL ROAD, 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-29
0
0001290149
Sierra Oncology, Inc.
SRRA
0001793762
Richardson Joshua
C/O SIERRA ONCOLOGY, INC.
2150 - 885 WEST GEORGIA STREET
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
1
0
1
0
Stock Option (Right to Buy)
0.3467
2019-11-29
4
A
0
60000
0.00
A
2029-11-29
Common Stock
60000
60000
D
Stock options were granted on November 29, 2019 in connection with the Reporting Person's appointment to the Issuer's Board of Directors on November 22, 2019.
The option vests as to 8.333% of the total shares monthly, beginning on December 29, 2019, with 100% of the total shares vested and exercisable on November 29, 2020, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Sukhi Jagpal as attorney-in-fact for Joshua Richardson
2019-12-03